Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added updated Study Status and Contacts/Locations sections (version 59, published 2026-03-25) and a deletion on 2026-02-17.
    Difference
    0.3%
    Check dated 2026-03-26T11:31:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:13.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 is added to the version history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:22.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Results and related sections have been posted (Results, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Status), and the prior 'Results Submitted' entry has been removed.
    Difference
    0.6%
    Check dated 2026-02-18T16:47:43.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added to the history; notices about government funding lapse and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:15:05.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record history updates to show Results Submitted and Revision: v3.4.1, replacing the previous No Results Posted status; a site-wide government funding notice was also added.
    Difference
    0.5%
    Check dated 2026-02-04T06:36:37.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.